Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1972 4
1973 1
1981 1
1986 8
1987 12
1988 13
1989 11
1990 10
1991 11
1992 22
1993 19
1994 22
1995 23
1996 24
1997 24
1998 26
1999 36
2000 41
2001 70
2002 80
2003 113
2004 132
2005 164
2006 199
2007 198
2008 272
2009 325
2010 406
2011 517
2012 527
2013 607
2014 674
2015 676
2016 708
2017 698
2018 761
2019 882
2020 1014
2021 1041
2022 61
Text availability
Article attribute
Article type
Publication date

Search Results

9,244 results
Results by year
Filters applied: . Clear all The following term was not found in PubMed: Joo-Yeun
Page 1
Golodirsen: First Approval.
Heo YA. Heo YA. Drugs. 2020 Feb;80(3):329-333. doi: 10.1007/s40265-020-01267-2. Drugs. 2020. PMID: 32026421 Review.
Fibrodysplasia ossificans progressiva: diagnosis, management, and therapeutic horizons.
Pignolo RJ, Shore EM, Kaplan FS. Pignolo RJ, et al. Pediatr Endocrinol Rev. 2013 Jun;10 Suppl 2(0 2):437-48. Pediatr Endocrinol Rev. 2013. PMID: 23858627 Free PMC article. Review.
Fibrodysplasia ossificans progressiva (FOP), a rare and disabling genetic condition characterized by congenital malformations of the great toes and progressive heterotopic endochondral ossification (HEO) which is the most catastrophic of HEO disorders in humans. ... …
Fibrodysplasia ossificans progressiva (FOP), a rare and disabling genetic condition characterized by congenital malformations of the great t …
Satralizumab: First Approval.
Heo YA. Heo YA. Drugs. 2020 Sep;80(14):1477-1482. doi: 10.1007/s40265-020-01380-2. Drugs. 2020. PMID: 32797372 Free PMC article. Review.
Won Do Heo.
Marx V. Marx V. Nat Methods. 2019 Nov;16(11):1067. doi: 10.1038/s41592-019-0626-1. Nat Methods. 2019. PMID: 31619776 No abstract available.
Revefenacin: First Global Approval.
Heo YA. Heo YA. Drugs. 2019 Jan;79(1):85-91. doi: 10.1007/s40265-018-1036-x. Drugs. 2019. PMID: 30560478 Free PMC article. Review.
GP2017: An Adalimumab Biosimilar.
Heo YA. Heo YA. BioDrugs. 2018 Dec;32(6):635-638. doi: 10.1007/s40259-018-0318-x. BioDrugs. 2018. PMID: 30460599 Review.
Baloxavir: First Global Approval.
Heo YA. Heo YA. Drugs. 2018 Apr;78(6):693-697. doi: 10.1007/s40265-018-0899-1. Drugs. 2018. PMID: 29623652 Review.
9,244 results